{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:51:26Z","timestamp":1773661886019,"version":"3.50.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/intimm\/dxh249","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T00:24:06Z","timestamp":1114043046000},"page":"695-704","source":"Crossref","is-referenced-by-count":53,"title":["Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells"],"prefix":"10.1093","volume":"17","author":[{"given":"Mario","family":"Amacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Engler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas R.","family":"Kammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Vadrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Oberholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Zurbriggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"key":"key\n\t\t\t\t20171012151054_BIB1","doi-asserted-by":"crossref","unstructured":"Almeida, J. D., Edwards, D. C., Brand, C. M. and Heath, T. D. 1975. Formation of virosomes from influenza subunits and liposomes. Lancet2:899.","DOI":"10.1016\/S0140-6736(75)92130-3"},{"key":"key\n\t\t\t\t20171012151054_BIB2","doi-asserted-by":"crossref","unstructured":"Gluck, R., Mischler, R., Brantschen, S., Just, M., Althaus, B. and Cryz, S. J., Jr. 1992. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. J. Clin. Invest.90:2491.","DOI":"10.1172\/JCI116141"},{"key":"key\n\t\t\t\t20171012151054_BIB3","doi-asserted-by":"crossref","unstructured":"Zurbriggen, R., Novak-Hofer, I., Seelig, A. and Gluck, R. 2000. IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization. Prog. Lipid Res.39:3.","DOI":"10.1016\/S0163-7827(99)00017-X"},{"key":"key\n\t\t\t\t20171012151054_BIB4","doi-asserted-by":"crossref","unstructured":"Zurbriggen, R. 2003. Immunostimulating reconstituted influenza virosomes. Vaccine21:921.","DOI":"10.1016\/S0264-410X(02)00541-8"},{"key":"key\n\t\t\t\t20171012151054_BIB5","unstructured":"Abrosch, F., Gluck, R. and Herzog, C. 1998. Clinical and immunological studies with a new virosome-based hepatitis A vaccine. In Proceeding of 2nd European Congress on Tropical Medicine, Federation of European Societies for Tropical Medicine and international Health Liverpool."},{"key":"key\n\t\t\t\t20171012151054_BIB6","doi-asserted-by":"crossref","unstructured":"Holzer, B. R., Hatz, C., Schmidt-Sissolak, D., Gluck, R., Althaus, B. and Egger, M. 1996. Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial. Vaccine14:982.","DOI":"10.1016\/0264-410X(96)00042-4"},{"key":"key\n\t\t\t\t20171012151054_BIB7","doi-asserted-by":"crossref","unstructured":"Conne, P., Gauthey, L., Vernet, P. et al.1997. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients. Vaccine15:1675.","DOI":"10.1016\/S0264-410X(97)00087-X"},{"key":"key\n\t\t\t\t20171012151054_BIB8","doi-asserted-by":"crossref","unstructured":"Cryz, S. J., Que, J. U. and Gluck, R. 1996. A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans. Vaccine14:1381.","DOI":"10.1016\/S0264-410X(96)00040-0"},{"key":"key\n\t\t\t\t20171012151054_BIB9","doi-asserted-by":"crossref","unstructured":"Gluck, R. and Wegmann, A. 1998. \u201cVirosomes,\u201d a new liposome-like vaccine delivery system. In Lasic, D. D. and Papahadjopoulos, D., eds, Medical Applications of Liposomes, p. 75. Elsevier, Amsterdam.","DOI":"10.1016\/B978-044482917-7\/50007-7"},{"key":"key\n\t\t\t\t20171012151054_BIB10","doi-asserted-by":"crossref","unstructured":"Wilson, I. A., Skehel, J. J. and Wiley, D. C. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature289:366.","DOI":"10.1038\/289366a0"},{"key":"key\n\t\t\t\t20171012151054_BIB11","doi-asserted-by":"crossref","unstructured":"Klenk, H. D., Rott, R., Orlich, M. and Blodorn, J. 1975. Activation of influenza A viruses by trypsin treatment. Virology68:426.","DOI":"10.1016\/0042-6822(75)90284-6"},{"key":"key\n\t\t\t\t20171012151054_BIB12","doi-asserted-by":"crossref","unstructured":"Durrer, P., Galli, C., Hoenke, S. et al.1996. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem.271:13417.","DOI":"10.1074\/jbc.271.23.13417"},{"key":"key\n\t\t\t\t20171012151054_BIB13","doi-asserted-by":"crossref","unstructured":"Tsurudome, M., Gluck, R., Graf, R., Falchetto, R., Schaller, U. and Brunner, J. 1992. Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion. J. Biol. Chem.267:20225.","DOI":"10.1016\/S0021-9258(19)88690-8"},{"key":"key\n\t\t\t\t20171012151054_BIB14","doi-asserted-by":"crossref","unstructured":"Matlin, K. S., Reggio, H., Helenius, A. and Simons, K. 1981. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol.91:601.","DOI":"10.1083\/jcb.91.3.601"},{"key":"key\n\t\t\t\t20171012151054_BIB15","doi-asserted-by":"crossref","unstructured":"Widmann, C., Maryanski, J. L., Romero, P. and Corradin, G. 1991. Differential stability of antigenic MHC class I-restricted synthetic peptides. J. Immunol.147:3745.","DOI":"10.4049\/jimmunol.147.11.3745"},{"key":"key\n\t\t\t\t20171012151054_BIB16","unstructured":"Vadrucci, S. 2002. Influenza Virus Hemagglutinin-mediated Membrane Fusion: Mechanistic Studies and Potential Applications. PhD Thesis. Federal Institute of Technology (ETH) Z\u00fcrich, Z\u00fcrich (http:\/\/e-collection.ethbib.ethz.ch\/cgi-bin\/show.pl?type=diss&nr=14765)."},{"key":"key\n\t\t\t\t20171012151054_BIB17","doi-asserted-by":"crossref","unstructured":"Hunziker, I. P., Grabscheid, B., Zurbriggen, R., Gluck, R., Pichler, W. J. and Cerny, A. 2002. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus. Int. Immunol.14:615.","DOI":"10.1093\/intimm\/dxf026"},{"key":"key\n\t\t\t\t20171012151054_BIB18","doi-asserted-by":"crossref","unstructured":"Zinkernagel, R. M., Callahan, G. N., Klein, J. and Dennert, G. 1978. Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature271:251.","DOI":"10.1038\/271251a0"},{"key":"key\n\t\t\t\t20171012151054_BIB19","doi-asserted-by":"crossref","unstructured":"Keene, J. A. and Forman, J. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med.155:768.","DOI":"10.1084\/jem.155.3.768"},{"key":"key\n\t\t\t\t20171012151054_BIB20","doi-asserted-by":"crossref","unstructured":"Bennett, S. R., Carbone, F. R., Karamalis, F., Miller, J. F. and Heath, W. R. 1997. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med.186:65.","DOI":"10.1084\/jem.186.1.65"},{"key":"key\n\t\t\t\t20171012151054_BIB21","doi-asserted-by":"crossref","unstructured":"Toes, R. E., Ossendorp, F., Offringa, R. and Melief, C. J. 1999. CD4 T cells and their role in antitumor immune responses. J. Exp. Med.189:753.","DOI":"10.1084\/jem.189.5.753"},{"key":"key\n\t\t\t\t20171012151054_BIB22","doi-asserted-by":"crossref","unstructured":"Arkema, A., Huckriede, A., Schoen, P., Wilschut, J. and Daemen, T. 2000. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes. Vaccine18:1327.","DOI":"10.1016\/S0264-410X(99)00404-1"},{"key":"key\n\t\t\t\t20171012151054_BIB23","doi-asserted-by":"crossref","unstructured":"Aichele, P., Brduscha-Riem, K., Zinkernagel, R. M., Hengartner, H. and Pircher, H. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med.182:261.","DOI":"10.1084\/jem.182.1.261"},{"key":"key\n\t\t\t\t20171012151054_BIB24","doi-asserted-by":"crossref","unstructured":"Liang, T. J., Rehermann, B., Seeff, L. B. and Hoofnagle, J. H. 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med.132:296.","DOI":"10.7326\/0003-4819-132-4-200002150-00008"},{"key":"key\n\t\t\t\t20171012151054_BIB25","doi-asserted-by":"crossref","unstructured":"Manns, M. P., McHutchison, J. G., Gordon, S. C. et al.2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet358:958.","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"key\n\t\t\t\t20171012151054_BIB26","doi-asserted-by":"crossref","unstructured":"Fried, M. W., Shiffman, M. L., Reddy, K. R. et al.2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med.347:975.","DOI":"10.1056\/NEJMoa020047"},{"key":"key\n\t\t\t\t20171012151054_BIB27","doi-asserted-by":"crossref","unstructured":"Chisari, F. V. 1997. Cytotoxic T cells and viral hepatitis. J. Clin. Invest.99:1472.","DOI":"10.1172\/JCI119308"},{"key":"key\n\t\t\t\t20171012151054_BIB28","doi-asserted-by":"crossref","unstructured":"Rehermann, B. and Chisari, F. V. 2000. Cell mediated immune response to the hepatitis C virus. Curr. Top. Microbiol. Immunol.242:299.","DOI":"10.1007\/978-3-642-59605-6_14"},{"key":"key\n\t\t\t\t20171012151054_BIB29","doi-asserted-by":"crossref","unstructured":"Cooper, S., Erickson, A. L., Adams, E. J. et al.1999. Analysis of a successful immune response against hepatitis C virus. Immunity10:439.","DOI":"10.1016\/S1074-7613(00)80044-8"},{"key":"key\n\t\t\t\t20171012151054_BIB30","doi-asserted-by":"crossref","unstructured":"Gruner, N. H., Gerlach, T. J., Jung, M. C. et al.2000. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J. Infect. Dis.181:1528.","DOI":"10.1086\/315450"},{"key":"key\n\t\t\t\t20171012151054_BIB31","doi-asserted-by":"crossref","unstructured":"Hitomi, Y., McDonnell, W. M., Killeen, A. A. and Askari, F. K. 1995. Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategies. J. Viral Hepat.2:235.","DOI":"10.1111\/j.1365-2893.1995.tb00035.x"},{"key":"key\n\t\t\t\t20171012151054_BIB32","doi-asserted-by":"crossref","unstructured":"Cerny, A., McHutchison, J. G., Pasquinelli, C. et al.1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest.95:521.","DOI":"10.1172\/JCI117694"},{"key":"key\n\t\t\t\t20171012151054_BIB33","doi-asserted-by":"crossref","unstructured":"Moreno, R., Jiang, L., Moehle, K. et al.2001. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design. Chembiochem2:838.","DOI":"10.1002\/1439-7633(20011105)2:11<838::AID-CBIC838>3.0.CO;2-4"},{"key":"key\n\t\t\t\t20171012151054_BIB34","doi-asserted-by":"crossref","unstructured":"Monnard, P. A., Oberholzer, T. and Luisi, P. 1997. Entrapment of nucleic acids in liposomes. Biochim. Biophys. Acta1329:39.","DOI":"10.1016\/S0005-2736(97)00066-7"},{"key":"key\n\t\t\t\t20171012151054_BIB35","doi-asserted-by":"crossref","unstructured":"Pascolo, S., Bervas, N., Ure, J. M., Smith, A. G., Lemonnier, F. A. and Perarnau, B. 1997. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J. Exp. Med.185:2043.","DOI":"10.1084\/jem.185.12.2043"},{"key":"key\n\t\t\t\t20171012151054_BIB36","doi-asserted-by":"crossref","unstructured":"Gerhard, W. 1976. The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin. J. Exp. Med.144:985.","DOI":"10.1084\/jem.144.4.985"},{"key":"key\n\t\t\t\t20171012151054_BIB37","doi-asserted-by":"crossref","unstructured":"Skehel, J. J. and Schild, G. C. 1971. The polypeptide composition of influenza A viruses. Virology44:396.","DOI":"10.1016\/0042-6822(71)90270-4"},{"key":"key\n\t\t\t\t20171012151054_BIB38","doi-asserted-by":"crossref","unstructured":"B\u00f6ttcher, C. J. F., Van Gent, C. M. and Pries, C. 1961. A rapid and sensitive sub-micro phosphorus determination. Anal. Chim. Acta24:203.","DOI":"10.1016\/0003-2670(61)80041-X"},{"key":"key\n\t\t\t\t20171012151054_BIB39","doi-asserted-by":"crossref","unstructured":"Ball, E. H. 1986. Quantitation of proteins by elution of Coomassie brilliant blue R from stained bands after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem.155:23.","DOI":"10.1016\/0003-2697(86)90218-6"},{"key":"key\n\t\t\t\t20171012151054_BIB40","doi-asserted-by":"crossref","unstructured":"Bron, R., Ortiz, A., Dijkstra, J., Stegmann, T. and Wilschut, J. 1993. Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes). Methods Enzymol.220:313.","DOI":"10.1016\/0076-6879(93)20091-G"},{"key":"key\n\t\t\t\t20171012151054_BIB41","doi-asserted-by":"crossref","unstructured":"Struck, D. K., Hoekstra, D. and Pagano, R. E. 1981. Use of resonance energy transfer to monitor membrane fusion. Biochemistry20:4093.","DOI":"10.1021\/bi00517a023"},{"key":"key\n\t\t\t\t20171012151054_BIB42","doi-asserted-by":"crossref","unstructured":"Loyter, A., Citovsky, V. and Blumenthal, R. 1988. The use of fluorescence dequenching measurements to follow viral membrane fusion events. Methods Biochem. Anal.33:129.","DOI":"10.1002\/9780470110546.ch4"},{"key":"key\n\t\t\t\t20171012151054_BIB43","doi-asserted-by":"crossref","unstructured":"Mastrobattista, E., Schoen, P., Wilschut, J., Crommelin, D. J. and Storm, G. 2001. Targeting influenza virosomes to ovarian carcinoma cells. FEBS Lett.509:71.","DOI":"10.1016\/S0014-5793(01)03112-X"},{"key":"key\n\t\t\t\t20171012151054_BIB44","doi-asserted-by":"crossref","unstructured":"Gluck, R. 1999. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs). Vaccine17:1782.","DOI":"10.1016\/S0264-410X(98)00440-X"},{"key":"key\n\t\t\t\t20171012151054_BIB45","doi-asserted-by":"crossref","unstructured":"Gunther-Ausborn, S., Praetor, A. and Stegmann, T. 1995. Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine. J. Biol. Chem.270:29279.","DOI":"10.1074\/jbc.270.49.29279"},{"key":"key\n\t\t\t\t20171012151054_BIB46","doi-asserted-by":"crossref","unstructured":"Shangguan, T., Alford, D. and Bentz, J. 1996. Influenza-virus-liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane. Biochemistry35:4956.","DOI":"10.1021\/bi9526903"},{"key":"key\n\t\t\t\t20171012151054_BIB47","doi-asserted-by":"crossref","unstructured":"Smit, J. M., Li, G., Schoen, P., Corver, J., Bittman, R., Lin, K. C. and Wilschut, J. 2002. Fusion of alphaviruses with liposomes is a non-leaky process. FEBS Lett.521:62.","DOI":"10.1016\/S0014-5793(02)02823-5"},{"key":"key\n\t\t\t\t20171012151054_BIB48","unstructured":"Waelti, E., Wegmann, N., Schwaninger, R. et al.2002. Targeting her-2\/neu with antirat Neu virosomes for cancer therapy. Cancer Res.62:437."},{"key":"key\n\t\t\t\t20171012151054_BIB49","doi-asserted-by":"crossref","unstructured":"Hunziker, I. P., Zurbriggen, R., Glueck, R. et al.2001. Perspectives: towards a peptide-based vaccine against hepatitis C virus. Mol. Immunol.38:475.","DOI":"10.1016\/S0161-5890(01)00083-9"},{"key":"key\n\t\t\t\t20171012151054_BIB50","doi-asserted-by":"crossref","unstructured":"Sarobe, P., Pendleton, C. D., Akatsuka, T. et al.1998. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. J. Clin. Invest.102:1239.","DOI":"10.1172\/JCI3714"},{"key":"key\n\t\t\t\t20171012151054_BIB51","doi-asserted-by":"crossref","unstructured":"Schumacher, R., Adamina, M., Zurbriggen, R. et al.2004. Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation. Vaccine22:714.","DOI":"10.1016\/j.vaccine.2003.08.019"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/17\/6\/695\/1952831\/dxh249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T01:06:27Z","timestamp":1683075987000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/intimm\/article\/17\/6\/695\/671220\/Peptideloaded-chimeric-influenza-virosomes-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,4,20]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxh249","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,4,20]]}}}